ARCA biopharma, Inc. Gains 90.06%
Wed, Apr 03, 2024 at 07:15 PM
ARCA biopharma, Inc. (ABIO:NASDAQ) jumped higher at $3.25, representing a gain of 90.1%. On Wed, Apr 03, 2024, ABIO:NASDAQ hit a New 2-Week High of $3.25. The stock got featured on our News Catalysts scanner on Wed, Apr 03, 2024 at 02:13 PM in the 'MERGER' category. From Wed, Mar 20, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
About ARCA biopharma, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 90.06%
- two Class A (TWOA:NYSE), 71.47%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 63.35%
- Mediaco Holding Inc. (MDIA:NASDAQ), 52.33%
- Aurora Cannabis Inc. (ACB:NASDAQ), 44.06%
- Aesthetic Medical International Holdings Group Limited (AIH:NASDAQ), 43.75%
- StoneBridge Acquisition Corporation (APAC:NASDAQ), 43.03%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.41%
- OneMedNet Corp. (ONMD:NASDAQ), 34.13%
- Asensus Surgical Inc. (ASXC:NYSEMKT), 33.55%